BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 7506675)

  • 1. Priming with recombinant human hematopoietic cytokines before bone marrow harvest expands in vivo and enhances ex vivo recovery of myeloid progenitors in short-term liquid cultures.
    Johnsen HE; Jensen L; Gaarsdal E; Hansen PB; Ersbøll J; Hansen NE
    Exp Hematol; 1994 Jan; 22(1):80-6. PubMed ID: 7506675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-term liquid marrow cultures are supported by a mixture of haematopoietic cytokines but do not purge for acute myeloid or lymphoid leukemic marrow cells.
    Johnsen HE; Gaarsdal E; Jensen L; Philip P; Hansen NE
    Leukemia; 1993 Sep; 7(9):1402-8. PubMed ID: 8371591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term in vivo priming of bone marrow haematopoiesis with rhG-CSF, rhGM-CSF or rhIL-3 before marrow harvest expands myelopoiesis but does not improve engraftment capability.
    Hansen PB; Knudsen H; Gaarsdal E; Jensen L; Ralfkiaer E; Johnsen HE
    Bone Marrow Transplant; 1995 Sep; 16(3):373-9. PubMed ID: 8535309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increase in peripheral blood megakaryocyte progenitors following cancer therapy with high-dose cyclophosphamide and hematopoietic growth factors.
    Siena S; Bregni M; Bonsi L; Sklenar I; Bagnara GP; Bonadonna G; Gianni AM
    Exp Hematol; 1993 Nov; 21(12):1583-90. PubMed ID: 7691640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ex vivo expansion of enriched peripheral blood CD34+ progenitor cells by stem cell factor, interleukin-1 beta (IL-1 beta), IL-6, IL-3, interferon-gamma, and erythropoietin.
    Brugger W; Möcklin W; Heimfeld S; Berenson RJ; Mertelsmann R; Kanz L
    Blood; 1993 May; 81(10):2579-84. PubMed ID: 7683923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The in vitro effects of granulocyte and granulocyte-macrophage colony-stimulating factor on interleukin-3-dependent proliferation of human neonatal circulating progenitor cells.
    Bedford Russell AR; Davies EG; Gibson FM; Gordon-Smith EC
    Pediatr Res; 1995 May; 37(5):630-3. PubMed ID: 7541523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetics of hematopoiesis in bone marrow cultures from patients with chronic myeloid leukemia: effect of recombinant cytokines in dexter-type long-term cultures.
    Luna-Bautista F; Sánchez-Valle E; Ayala-Sánchez M; Morales-Polanco M; Meillon-García L; Benítez-Bribiesca L; Mayani H
    Hematology; 2003 Jun; 8(3):155-63. PubMed ID: 12745649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antagonistic effects of interleukin 6 and G-CSF in the later stage of human granulopoiesis in vitro.
    Katayama K; Koizumi S; Ueno Y; Ohno I; Ichihara T; Horita S; Miyawaki T; Taniguchi N
    Exp Hematol; 1990 Jun; 18(5):390-4. PubMed ID: 1692536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative and cell-cycle differences in progenitor cells mobilized by recombinant human interleukin-7 and recombinant human granulocyte colony-stimulating factor.
    Grzegorzewski KJ; Komschlies KL; Franco JL; Ruscetti FW; Keller JR; Wiltrout RH
    Blood; 1996 Dec; 88(11):4139-48. PubMed ID: 8943848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant human interleukin-3 (rhIL-3) enhances the mobilization of peripheral blood progenitor cells by recombinant human granulocyte colony-stimulating factor (rhG-CSF) in normal volunteers.
    Huhn RD; Yurkow EJ; Tushinski R; Clarke L; Sturgill MG; Hoffman R; Sheay W; Cody R; Philipp C; Resta D; George M
    Exp Hematol; 1996 Jun; 24(7):839-47. PubMed ID: 8647235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-11 stimulates the proliferation of human hematopoietic CD34+ and CD34+CD33-DR- cells and synergizes with stem cell factor, interleukin-3, and granulocyte-macrophage colony-stimulating factor.
    Lemoli RM; Fogli M; Fortuna A; Motta MR; Rizzi S; Benini C; Tura S
    Exp Hematol; 1993 Dec; 21(13):1668-72. PubMed ID: 7694867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant human stem cell factor enhances the formation of colonies by CD34+ and CD34+lin- cells, and the generation of colony-forming cell progeny from CD34+lin- cells cultured with interleukin-3, granulocyte colony-stimulating factor, or granulocyte-macrophage colony-stimulating factor.
    Bernstein ID; Andrews RG; Zsebo KM
    Blood; 1991 Jun; 77(11):2316-21. PubMed ID: 1710148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Porcine brain microvascular endothelial cells support the in vitro expansion of human primitive hematopoietic bone marrow progenitor cells with a high replating potential: requirement for cell-to-cell interactions and colony-stimulating factors.
    Davis TA; Robinson DH; Lee KP; Kessler SW
    Blood; 1995 Apr; 85(7):1751-61. PubMed ID: 7535587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions of tumor necrosis factor with granulocyte-macrophage colony-stimulating factor and other cytokines in the regulation of dendritic cell growth in vitro from early bipotent CD34+ progenitors in human bone marrow.
    Reid CD; Stackpoole A; Meager A; Tikerpae J
    J Immunol; 1992 Oct; 149(8):2681-8. PubMed ID: 1383322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-term rhG-CSF priming before chemotherapy does mobilize blood progenitors but does not prevent chemotherapy induced myelotoxicity: a randomized study of patients with non-Hodgkin's lymphomas.
    Hansen PB; Johnsen HE; Ralfkiaer E; Jensen L; Gaarsdal E; Hansen NE
    Leuk Lymphoma; 1995 Nov; 19(5-6):453-60. PubMed ID: 8590846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative effects of granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF) on priming peripheral blood progenitor cells for use with autologous bone marrow after high-dose chemotherapy.
    Peters WP; Rosner G; Ross M; Vredenburgh J; Meisenberg B; Gilbert C; Kurtzberg J
    Blood; 1993 Apr; 81(7):1709-19. PubMed ID: 7681699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant human stem cell factor synergises with GM-CSF, G-CSF, IL-3 and epo to stimulate human progenitor cells of the myeloid and erythroid lineages.
    McNiece IK; Langley KE; Zsebo KM
    Exp Hematol; 1991 Mar; 19(3):226-31. PubMed ID: 1704845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mobilization of peripheral blood progenitor cells by sequential administration of interleukin-3 and granulocyte-macrophage colony-stimulating factor following polychemotherapy with etoposide, ifosfamide, and cisplatin.
    Brugger W; Bross K; Frisch J; Dern P; Weber B; Mertelsmann R; Kanz L
    Blood; 1992 Mar; 79(5):1193-200. PubMed ID: 1371415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined use of growth factors to stimulate the proliferation of hematopoietic progenitor cells after autologous bone marrow transplantation for lymphoma patients.
    Lemoli RM; Fortuna A; Fogli M; Rosti G; Gherlinzoni F; Visani G; Catani L; Gozzetti A; Tura S
    Acta Haematol; 1996; 95(3-4):164-70. PubMed ID: 8677737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.